Johnson & Johnson (JNJ) Launches Shockwave C2 Catheter for Coronary Procedures

AI Summary

Johnson & Johnson (JNJ) announced the launch of the Shockwave C2 Aero coronary catheter designed to treat coronary artery disease. This device aims to improve patient outcomes by facilitating easier and more effective treatments. The introduction of such innovative products could enhance JNJ's market position in the cardiovascular segment. As the demand for advanced medical technologies continues to grow, this launch may positively influence JNJ's market performance.